CTOs on the Move

Bodyport

www.bodyport.com

 
Bodyport is the platform for health in the home. Understand your body on a deeper level. Predict and prevent disease.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Bodyport raised $11.2M on 08/11/2020

Similar Companies

Universal Rhblttion Ftnes Inst

Universal Rhblttion Ftnes Inst is a Livingston, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HOYA Vision Care Canada

HOYA Vision Care Canada is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Parkview Adventist Medical Center

Parkview Adventist Medical Center is a Brunswick, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

St. Paul County Family and Community Support Services

St. Paul County Family and Community Support Services is a St Paul, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.